
### [NCIT:C5821](http://purl.obolibrary.org/obo/NCIT_C5821)
**Label:** Esophageal Neuroendocrine Neoplasm

**Subclasses:** [NCIT:C95617](http://purl.obolibrary.org/obo/NCIT_C95617) (Esophageal Neuroendocrine Tumor G2), [NCIT:C95616](http://purl.obolibrary.org/obo/NCIT_C95616) (Esophageal Neuroendocrine Tumor), [NCIT:C5820](http://purl.obolibrary.org/obo/NCIT_C5820) (Esophageal Neuroendocrine Tumor G1), [NCIT:C95620](http://purl.obolibrary.org/obo/NCIT_C95620) (Esophageal Large Cell Neuroendocrine Carcinoma), [NCIT:C6762](http://purl.obolibrary.org/obo/NCIT_C6762) (Esophageal Small Cell Neuroendocrine Carcinoma), [NCIT:C95619](http://purl.obolibrary.org/obo/NCIT_C95619) (Esophageal Neuroendocrine Carcinoma), 

**Class expressions from DL-Learner:**

- [UBERON:0001043](http://purl.obolibrary.org/obo/UBERON_0001043) (esophagus) 75.00%
- [NCIT:C2980](http://purl.obolibrary.org/obo/NCIT_C2980) (Dysphagia) 75.00%
- Thing 50.92%
- [NCIT:C3368](http://purl.obolibrary.org/obo/NCIT_C3368) (Digestive System Signs and Symptoms) 38.36%
- [NCIT:C36279](http://purl.obolibrary.org/obo/NCIT_C36279) (Digestive System Finding) 37.13%
- [NCIT:C100104](http://purl.obolibrary.org/obo/NCIT_C100104) (Sign or Symptom) 30.85%
- [NCIT:C36278](http://purl.obolibrary.org/obo/NCIT_C36278) (Finding by Site or System) 29.03%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 26.78%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 26.36%
- [UBERON:0010000](http://purl.obolibrary.org/obo/UBERON_0010000) (multicellular anatomical structure) 26.31%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 26.28%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 26.21%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 26.13%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 26.12%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 26.03%


